TSS
GCVRZ

Two Sigma Securities’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Two Sigma Securities’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-15,918
Closed -$8K – 2684
2019
Q2 		$8K Sell
15,918
-12,738
-44% -$6.36K ﹤0.01% 2010
2019
Q1 		$13K Sell
28,656
-1,712
-6% -$799 ﹤0.01% 1713
2018
Q4 		$15K Buy
+30,368
New +$15.1K ﹤0.01% 1991
2018
Q3 		– Sell
-15,497
Closed -$8K – 3263
2018
Q2 		$8K Sell
15,497
-11,323
-42% -$5.28K ﹤0.01% 2594
2018
Q1 		$11K Buy
+26,820
New +$10.8K ﹤0.01% 2609
2017
Q1 		– Sell
-10,153
Closed -$4K – 1279
2016
Q4 		$4K Sell
10,153
-1,688
-14% -$571 ﹤0.01% 689
2016
Q3 		$3K Buy
+11,841
New +$3K ﹤0.01% 641
2016
Q1 		– Sell
-18,556
Closed -$2K – 498
2015
Q4 		$2K Buy
18,556
+3,403
+22% +$481 ﹤0.01% 262
2015
Q3 		$3K Buy
+15,153
New +$5.15K ﹤0.01% 213

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Two Sigma Securities's GCVRZ Position: Q3 2019 in Review

Two Sigma Securities sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2019, closing a stake of 15,918 shares — an estimated $8K sold.

Two Sigma Securities first reported a position in GCVRZ in Q3 2015 and held it in 9 quarters. The position peaked at $15K in Q4 2018. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2019.

  • Two Sigma Securities reported no remaining Sanofi Contingent Value Rights position as of Q3 2019 after selling out during the quarter.
  • Two Sigma Securities sold 15,918 Sanofi Contingent Value Rights shares in Q3 2019, an estimated $8K.
  • Two Sigma Securities first reported a position in Sanofi Contingent Value Rights in Q3 2015 and held it in 9 quarters.
  • Two Sigma Securities's Sanofi Contingent Value Rights position peaked at $15K in Q4 2018.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2019.

Based on Two Sigma Securities's 13F filing for Q3 2019, filed 14 Nov 2019.